Introduction: A New Era in Diabetes and Peripheral Artery Disease Treatment The emergence of new evidence in treating peripheral artery disease (PAD) among patients with type 2 diabetes is transforming how we think about care. Recent findings from the STRIDE trial have sparked conversations among clinicians and researchers alike, suggesting that semaglutide—marketed as Ozempic—might offer […] More